Tudor Investment Corp’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.57M | Buy |
18,225
+15,157
| +494% | +$2.94M | 0.01% | 1426 |
|
|
2025
Q4 | $532K | Buy |
+3,068
| New | +$559K | ﹤0.01% | 2699 |
|
|
2025
Q1 | – | Sell |
-7,608
| Closed | -$1.25M | – | 3195 |
|
|
2024
Q4 | $1.15M | Buy |
+7,608
| New | +$1.18M | ﹤0.01% | 1638 |
|
|
2022
Q4 | – | Sell |
-66,310
| Closed | -$9.53M | – | 2482 |
|
|
2022
Q3 | $8.14M | Buy |
+66,310
| New | +$8.73M | 0.18% | 110 |
|
|
2022
Q2 | – | Sell |
-42,092
| Closed | -$5.74M | – | 2194 |
|
|
2022
Q1 | $5.76M | Sell |
42,092
-22,555
| -35% | -$3.14M | 0.13% | 178 |
|
|
2021
Q4 | $11.2M | Buy |
64,647
+28,535
| +79% | +$4.34M | 0.19% | 95 |
|
|
2021
Q3 | $5.25M | Sell |
36,112
-25,708
| -42% | -$3.76M | 0.09% | 253 |
|
|
2021
Q2 | $8.16M | Buy |
61,820
+8,223
| +15% | +$1.08M | 0.15% | 111 |
|
|
2021
Q1 | $6.88M | Sell |
53,597
-14,613
| -21% | -$1.8M | 0.14% | 115 |
|
|
2020
Q4 | $8.13M | Buy |
68,210
+59,256
| +662% | +$7.22M | 0.23% | 55 |
|
|
2020
Q3 | $1.02M | Buy |
+8,954
| New | +$1.06M | 0.04% | 554 |
|
|
2018
Q4 | – | Sell |
-21,857
| Closed | -$2.36M | – | 1059 |
|
|
2018
Q3 | $2.36M | Buy |
21,857
+8,406
| +62% | +$922K | 0.06% | 242 |
|
|
2018
Q2 | $1.48M | Buy |
13,451
+9,475
| +238% | +$987K | 0.05% | 319 |
|
|
2018
Q1 | $399K | Buy |
+3,976
| New | +$407K | 0.01% | 640 |
|
|
2017
Q4 | – | Sell |
-23,603
| Closed | -$2.21M | – | 1111 |
|
|
2017
Q3 | $2.21M | Buy |
+23,603
| New | +$2.51M | 0.06% | 192 |
|
|
2016
Q4 | – | Sell |
-6,000
| Closed | -$508K | – | 1437 |
|
|
2016
Q3 | $508K | Hold |
6,000
| – | – | 0.01% | 724 |
|
|
2016
Q2 | $488K | Sell |
6,000
-786
| -12% | -$59.9K | 0.01% | 852 |
|
|
2016
Q1 | $485K | Sell |
6,786
-3,762
| -36% | -$252K | 0.01% | 962 |
|
|
2015
Q4 | $750K | Sell |
10,548
-6,812
| -39% | -$458K | 0.02% | 620 |
|
|
2015
Q3 | $1.07M | Sell |
17,360
-408
| -2% | -$28.5K | 0.04% | 365 |
|
|
2015
Q2 | $1.29M | Buy |
17,768
+3,324
| +23% | +$245K | 0.04% | 322 |
|
|
2015
Q1 | $1.11M | Buy |
14,444
+4,844
| +50% | +$347K | 0.04% | 337 |
|
|
2014
Q4 | $644K | Buy |
+9,600
| New | +$606K | 0.02% | 589 |
|
|
2014
Q3 | – | Sell |
-8,400
| Closed | -$493K | – | 1371 |
|
|
2014
Q2 | $493K | Sell |
8,400
-397,667
| -98% | -$23.3M | 0.02% | 542 |
|
|
2014
Q1 | $23.5M | Buy |
406,067
+379,378
| +1,421% | +$20.3M | 1% | 16 |
|
|
2013
Q4 | $1.43M | Buy |
26,689
+23,089
| +641% | +$1.37M | 0.07% | 127 |
|
|
2013
Q3 | $222K | Buy |
+3,600
| New | +$215K | 0.01% | 702 |
|
Other funds holding DGX
VCM
VPM
EIG
Tudor Investment Corp's DGX Position: Q1 2026 in Review
Tudor Investment Corp increased its Quest Diagnostics (DGX) stake by 494% in Q1 2026, buying an estimated $2.94M and bringing the position to 18,225 shares worth $3.57M. The position accounts for 0.01% of the portfolio, ranked #1426.
Tudor Investment Corp first reported a position in DGX in Q3 2013 and has held it in 27 quarters since. The position peaked at $23.5M in Q1 2014. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.
- Tudor Investment Corp held 18,225 shares of Quest Diagnostics worth $3.57M as of Q1 2026.
- Tudor Investment Corp bought 15,157 Quest Diagnostics shares in Q1 2026, an estimated $2.94M.
- Quest Diagnostics made up 0.01% of Tudor Investment Corp's portfolio in Q1 2026, its #1426 holding.
- Tudor Investment Corp first reported a position in Quest Diagnostics in Q3 2013 and has held it in 27 quarters since.
- Tudor Investment Corp's Quest Diagnostics position peaked at $23.5M in Q1 2014.
- 1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.
Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.